AFM13

Ash 2022 preview – Affimed and Aptose score
EP Vantage
Sun, 11/6/22 - 01:24 pm
ASH 2022
Affimed
Aptose Biosciences
ADI-001
CAR-T
AFM13
AACR 2022 – Affimed shows that 2021 was no fluke
EP Vantage
Mon, 04/11/22 - 10:26 am
AACR
Affimed
AFM13
natural killer cells
AACR 2021 – Affimed wins, Oncternal loses
EP Vantage
Mon, 04/12/21 - 10:34 am
AACR
Affimed
AFM13
Oncternal
clinical trials